Streetbeat News

Analyst Ratings

GILD

Gilead Sciences's (NYSE:GILD) short percent of float has risen 4.14% since its last report, with 19.63 million shares sold short, which is 1.76% of all regular shares available for trading. It would take traders 3.89 days to cover their short positions on average. An increase in short interest can signal that investors have become more bearish. Gilead Sciences's peer group average for short interest as a percentage of float is 3.80%, which means the company has less short interest than most of its peers.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 2:30 pm

PRU

Prudential Financial's (NYSE:PRU) short percent of float has fallen 7.43% since its last report, with 4.98 million shares sold short, which is 1.37% of all regular shares available for trading. This decrease in short interest could indicate a more bullish market sentiment towards the stock. However, compared to its peers, Prudential Financial has less short interest.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 2:30 pm

VEEV

Veeva Systems' (NYSE:VEEV) short percent of float has risen 5.7% since its last report, with 4.02 million shares sold short, which is 2.78% of all regular shares available for trading. It would take traders 6.2 days to cover their short positions on average. The company's short interest is less than its peer group average of 6.55%.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 2:30 pm

AMC

B. Riley Securities analyst Eric Wold has maintained a Neutral rating on AMC Enter Hldgs (NYSE:AMC) and raised the price target from $4.5 to $45.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 2:30 pm

WBA

Truist Securities analyst David Macdonald has reiterated a 'Hold' rating on Walgreens Boots Alliance (NASDAQ:WBA) and maintained a price target of $30.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 2:23 pm

ENSG

Truist Securities analyst David Macdonald has reiterated a 'Hold' rating on Ensign Group (NASDAQ:ENSG) and maintained a price target of $110.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 2:23 pm

SUM

Truist Securities analyst Rohit Seth has reiterated a 'Buy' rating on Summit Materials (NYSE:SUM) and maintained a price target of $48.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 2:22 pm

GMED

Truist Securities analyst Richard Newitter has reiterated a 'Hold' rating on Globus Medical (NYSE:GMED) and maintained a price target of $65.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 2:21 pm

AMGN

Truist Securities analyst Robyn Karnauskas has reiterated a 'Hold' rating on Amgen (NASDAQ:AMGN) and maintained a price target of $260.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 2:21 pm